Screen Shot 2021-09-01 at 1.19.19 PM.png
 

ABOUT US

Button Capital is a community of people who are committed to life sciences and medical technology through searching and investing in right people and right team.

Right People & Right Team - strong curiosity and proactive customer orientation are two key attributes.

aboutUs-img.png
Wave

CORE VALUES

Focus

We are dedicated to life sciences and medical technology.​

f.png

Passion

We truly love what we do! We believe that our passion will lead us right into our purpose.​

p.png

Excellence

We are driven to achieve excellence in our work through persistence and continuous improvement.​

e.png

Collaboration

We partner with people to create values for the community and achieve a win-win cooperation.

c.png
 
Sea Shore

WHAT WE DO

Button Capital is focused on bringing innovative life sciences and medical technology to where they are needed.

 

We focus on facilitating the growth of early stage life sciences ventures by providing capital investment.

 

PORTFOLIO

Screen Shot 2021-04-26 at 12.28.03 AM.png

Xcision is a medical technology company developing advanced stereotactic radiotherapy solutions with the potential to significantly improve the quality of cancer care.

flowpharma-logo_edited.jpg

FlowPharma uses computational modeling and AI deep learning to design synthetic, CTL Immuno-Oncology therapeutics.

questgonomics_edited.jpg

Quest Genomics is research and development company focusing on  tumor genetic testing instruments and reagents.

logo_edited.jpg

(Acquired)

Versl leverages its proprietary technology and massive doctor networking to champion the service of eye screening for new born babies in China.

Screen Shot 2021-04-26 at 12.26.42 AM.png

EPIN is a leading MedTech CRO in China providing one-stop service.

Screen Shot 2021-04-26 at 12.25.37 AM.png

LakeBio focuses on molecular diagnosis. It develops an innovative molecular diagnosis system that provides clients one-stop services.

Sinorda.jpeg

Sinorda is a biotech company from Sweden focusing on the project portfolio in clinical phases with fast development time and low risk.

ART.png

ART develops a novel, resin-based, drug delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies. 

 

news

 

October 9, 2021

Sinorda has closed a transcation with Shanghai Pharmaceuticals, which obtained the exclusive rights from Sinorda to produce APIs and preparations for X842, a new acid inhibitor.
 

Contact

Screen Shot 2021-09-01 at 6.58.45 PM.png

Silicon Valley

2665 Marine Way

Mountain View, CA 94043

Shanghai at Dusk

shanghai

738 Dongfang Road,

Pudong District, Shanghai, China

contact-img02.png

hefei

Fund Mansion, High-tech Zone,

Hefei City, Anhui Province, China

©2015-2021 Button Capital. All rights reserved.